Cargando…

Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma

Hedgehog inhibitors are promising alternative treatments for patients with advanced basal cell carcinomas. Sonidegib (Odomzo(®)), an oral smoothened (SMO) antagonist, is indicated for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) who present recurrence following...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villani, Alessia, Fabbrocini, Gabriella, Costa, Claudia, Scalvenzi, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211768/ https://www.ncbi.nlm.nih.gov/pubmed/32297221 http://dx.doi.org/10.1007/s13555-020-00378-8

Ejemplares similares

Sonidegib treatment in patients with locally advanced basal cell carcinoma
por: Villani, Alessia, et al.
Publicado: (2022)

Sonidegib with and Without Adjunctive Treatment for Locally Advanced Basal Cell Carcinomas
por: Villani, Alessia, et al.
Publicado: (2022)

Sonidegib‐induced muscle spasms in the treatment of basal cell carcinoma: Strategies to adopt
por: Villani, Alessia, et al.
Publicado: (2022)

The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area
por: Villani, Alessia, et al.
Publicado: (2023)

Giant basal cell carcinoma of the vulva successfully treated with Sonidegib
por: Camela, Elisa, et al.
Publicado: (2022)

Vismodegib treatment in advanced basal cell carcinomas: Real‐life experience
por: Villani, Alessia, et al.
Publicado: (2021)

New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
por: Villani, Alessia, et al.
Publicado: (2022)

Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment
por: Villani, Alessia, et al.
Publicado: (2020)

Systemic hedgehog inhibitors to treat locally advanced basal cell carcinomas of the head–neck region: A retrospective study
por: Villani, Alessia, et al.
Publicado: (2021)

Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case
por: Villani, Alessia, et al.
Publicado: (2021)

Long‐term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID‐19 pandemic
por: Villani, Alessia, et al.
Publicado: (2022)

Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity
por: Scalvenzi, Massimiliano, et al.
Publicado: (2020)

Sonidegib for the Treatment of Advanced Basal Cell Carcinoma
por: Brancaccio, Gabriella, et al.
Publicado: (2020)

Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test
por: Villani, Alessia, et al.
Publicado: (2019)

Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies
por: Villani, Alessia, et al.
Publicado: (2019)

Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma
por: Doan, Hung Q, et al.
Publicado: (2016)

The Treatment of Advanced Melanoma: Therapeutic Update
por: Villani, Alessia, et al.
Publicado: (2022)

Differential pharmacology and clinical utility of sonidegib in advanced basal cell carcinoma
por: Wahid, Mohd, et al.
Publicado: (2017)

Effective systemic treatment of advanced periocular basal cell carcinoma with sonidegib
por: Rokohl, Alexander C., et al.
Publicado: (2021)

Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire
por: Camela, Elisa, et al.
Publicado: (2023)

Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt
por: Villani, Alessia, et al.
Publicado: (2020)

Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas
por: Jain, Sachin, et al.
Publicado: (2017)

Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study
por: HERMS, Florian, et al.
Publicado: (2022)

Experience with sonidegib in patients with advanced basal cell carcinoma: case reports
por: Puig, Susana, et al.
Publicado: (2022)

Nevoid hyperkeratosis of the nipple mimicking a pigmented basal cell carcinoma
por: Mazzella, Caterina, et al.
Publicado: (2016)

Benefit–risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma
por: García Ruiz, Antonio J, et al.
Publicado: (2022)

Cutaneous Bowen’s Disease: an Analysis of 182 Cases according To Age, Sex, and Anatomical Site from an Italian Center
por: Scalvenzi, Massimiliano, et al.
Publicado: (2019)

Reflectance confocal microscopy for Kaposi's sarcoma treatment monitoring after intralesional vincristine chemotherapy
por: Villani, Alessia, et al.
Publicado: (2022)

Clinical, dermoscopic and histological features of a combined tumor composed of a melanoma in situ, a basal cell carcinoma and an intradermal naevus
por: Scalvenzi, Massimiliano, et al.
Publicado: (2012)

Long-Term Efficacy of Vismodegib After its Withdrawal and Patients’ Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI)
por: Villani, Alessia, et al.
Publicado: (2019)

A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma
por: Odom, Dawn, et al.
Publicado: (2017)

First reported case of concurrent sonidegib and radiotherapy for recurrent, advanced basal cell carcinoma
por: Wang, Kaidi, et al.
Publicado: (2021)

Intracranial regression of an advanced basal cell carcinoma using sonidegib and itraconazole after failure with vismodegib
por: Yoon, Jaeyoung, et al.
Publicado: (2017)

Expression of Glioma-associated oncogene homolog 1 as biomarker with sonidegib in advanced basal cell carcinoma
por: Dummer, Reinhard, et al.
Publicado: (2020)

Rapid and exceptional response to Sonidegib in a patient with multiple locally advanced basal cell carcinomas
por: Tarantino, Vanessa, et al.
Publicado: (2021)

Optimizing the pharmacokinetics of sonidegib in small bowel syndrome and advanced basal cell carcinoma: Our solution
por: Grubbs, Hailey, et al.
Publicado: (2023)

Looking into a Better Future: Novel Therapies for Metastatic Melanoma
por: Villani, Alessia, et al.
Publicado: (2021)

Clinical Clearance Following Improvement of Histologic Subtype of Basal Cell Carcinoma with Sonidegib
por: LEOW, Liang Joo, et al.
Publicado: (2022)

Multicenter Retrospective Andalusian Study of the Use of Sonidegib for the Treatment of Local Advanced Basal Cell Carcinoma in Real Clinical Practice
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2023)

Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study
por: Lear, J.T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5ok9tvuell3ktbc0plql95saro